Shawnalea Frazier

Novo Ventures, Novo Ventures (US) Inc.

Shawna joined Novo Ventures (US) Inc., San Francisco, California in 2015.

Previously, she served as Executive Director of Business Development at VxP Pharma, a service company facilitating contractual collaborations in discovery, development, and manufacturing in the life science industry. In addition, Shawna was Co-Founder and Scientific Advisor of a Bay Area startup developing platform technology relevant to neurological and ocular indications. Her research experience spans the areas of cellular physiology and molecular engineering with applications to biological therapeutics and gene therapy.

Shawna received her PhD in Biochemistry & Molecular Biophysics with an emphasis in Neuroscience from the California Institute of Technology (Caltech). Prior to she earned combined BS and Master’s degrees from Kansas State University in Biochemistry in an accelerated 5 year program.